Utah allows Doctronic AI to prescribe medications in experiment
Updated
Updated · The Washington Post · Apr 30
Utah allows Doctronic AI to prescribe medications in experiment
14 articles · Updated · The Washington Post · Apr 30
The programme focuses on low-acuity prescription renewals, with co-founder Matt Pavelle saying Utah-licensed clinicians, not original prescribers, are listed on scripts.
Supporters say it could speed refills for patients between doctors and reduce emergencies from missed medicines, while freeing physicians for more complex care.
Critics including the Utah Medical Association and University of Utah experts warn about patient safety, missed preventive care and unresolved liability despite Doctronic's AI malpractice insurance.
If AI can predict medication risks and streamline care, why do medical leaders remain so wary—what hidden dangers might these systems introduce to patient health?
With legal liability for AI prescribing still unclear, what happens when an automated refill leads to harm—can a machine truly be held accountable?
23% Faster Prescription Renewals in Utah’s Controversial AI-Driven Healthcare Experiment
Overview
In December 2025, Utah and Doctronic launched a pioneering AI pilot to autonomously renew prescriptions for 190 low-risk medications, aiming to reduce refill delays and improve medication adherence. The program operates under Utah's Regulatory Sandbox with phased human oversight and strict safety measures. Despite early success showing faster refills, high patient satisfaction, and strong AI-physician agreement, the Utah Medical Licensing Board opposed the pilot over safety and procedural concerns. A public AI jailbreak incident further damaged trust, highlighting cybersecurity risks. The pilot exposes regulatory gaps and liability challenges, yet its promising results have sparked plans for expansion and national attention as a model for AI-driven healthcare innovation.